Definitive Contract HR001121C0148

Award Date 5/28/21
Potential Completion Date 3/25/22
Potential Value $219K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77021, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovative Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Autonomous Healthcare Inc., a for-profit Subchapter S corporation. The $224,459 Firm Fixed Price contract is for the development of an "Automated System for Hemorrhage Control and Resuscitation at Point of Injury", which aligns with DARPA's mission to provide game-changing capabilities to warfighters. The original solicitation was a Broad Agency...
This is a $1,484,722.00 Cost Plus Fixed Fee contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Zymeron Corporation, a minority-owned small business located in Research Triangle Park, North Carolina. The contract was awarded under DARPA's Small Business Innovation Research (SBIR) program, Phase II, for the development of an "Automated Partial Occlusion for Truncal Hemorrhage Control" technology. This Phase II award builds upon earlier SBIR work and is...
This federal contract award was issued by the Defense Health Agency (DHA) to Hybrid Plastics, Incorporated, a for-profit manufacturer, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $999,997.59, is for the development of a "Hemostatic Agent" under the DHA PHASE II SBIR H2-0265 project. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the period of performance is from the award date of September 15, 2017...
This firm fixed-price contract was awarded by the Defense Advanced Research Projects Agency (DARPA) to Creare LLC, doing business as Creare, for a Small Business Innovation Research (SBIR) Phase I project on the "Development of a Smart REBOA Catheter" to support "Smart Hemorrhage Control and Resuscitation at Point of Injury". The total potential value of the contract is $224,545.00. Creare is a small business engineering research and development company that has extensive...
This is a $150,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Critical Innovations LLC, a small business medical research and development company. The contract is for the SBIR DHP PHASE I PROPOSAL H161-011-0011, which involves the development of innovative solutions for military and pre-hospital healthcare applications. Critical Innovations specializes in advanced medical technologies such as wound treatment, hemorrhage...
This is a firm fixed price purchase order contract awarded by the Air Force Research Laboratory to Daxor Corporation, a small disadvantaged business, for the Far Forward and En Route Decision Assist in the Treatment of Hemorrhage under the Small Business Innovation Research (SBIR) Program Phase II. The contract has a ceiling value of $749,967.00 and is set to expire on August 15, 2024. Daxor Corporation, the prime contractor, is a medical instrumentation and biotechnology company that provides...
This is a $224,299.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Software Factory Labs Inc., a for-profit small business organization. The contract is for a Phase I Small Business Technology Transfer (STTR) research and development project focused on developing "game-changing capabilities" to support DARPA's mission. The contract was awarded under a DARPA Broad Agency Announcement that will issue research opportunity notices on an...
This is a $223,008 firm fixed-price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Federal Foundry LLC, a Veteran-Owned Small Business. The contract is for R&D under the Small Business Technology Transfer (STTR) Phase I program. It is associated with a DARPA SBIR/STTR broad agency announcement, which allows the agency to issue funding opportunities on an "as-needed" basis to support its mission of ensuring technological superiority for the United...
This is a $1,649,996.73 firm-fixed-price contract awarded by the Defense Health Agency (DHA) to Daxor Corporation, a self-certified small disadvantaged business, for Phase II of the Small Business Innovation Research (SBIR) program. The contract, with a period of performance from July 2023 to November 2025, is for research and development related to hemorrhage treatment and blood volume analysis technologies to support combat casualty care. This contract is a set-aside for small businesses and...
This is a $250,000.00 Firm Fixed Price Purchase Order awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a small business, under the DHA's Small Business Innovation Research (SBIR) program. The contract is for the development of the AID-TEX Wearable E-Textile System for Control of Junctional and Extremity Hemorrhage, a medical research and development project focused on innovative solutions for military and pre-hospital healthcare applications. The contract has a period of...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to JSL Innovations LLC, a small business, for the development of an Automated Hemorrhage Control Device. The contract has a ceiling value of $218,930.00 and a period of performance ending on March 25, 2022. The award was made on May 28, 2021 under a Broad Agency Announcement that sought proposals for SBIR and Small Business Technology Transfer (STTR) funding opportunities to advance DARPA's mission. The contract is a Firm Fixed Price Definitive Contract.

Generated 8/12/24, 9:30 AM